Overview Proxalutamide Treatment for Hospitalized COVID-19 Patients Status: Completed Trial end date: 2021-04-15 Target enrollment: Participant gender: Summary The purpose of this study is to assess the efficacy and safety of Proxalutamide as a treatment for hospitalized COVID-19 male and female patients. Phase: Phase 3 Details Lead Sponsor: Applied Biology, Inc.